The adult growth hormone deficiency syndrome

Advances in Internal Medicine

Volumn 45, Issue , 2000, Pages 297-315

  Cook, David M ^a   Ludlam, William H ^a   Cook, Marie B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ADULT; BLOOD; DIFFERENTIAL DIAGNOSIS; DOCTOR PATIENT RELATION; DRUG MONITORING; FEMALE; HUMAN; MALE; MIDDLE AGED; PATIENT SATISFACTION; REVIEW; SYNDROME;

ADULT; DIAGNOSIS, DIFFERENTIAL; DRUG MONITORING; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHYSICIAN-PATIENT RELATIONS; SYNDROME;

EID: 0033630226     PISSN: 00652822     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Jørgensen JOL, Theusen L, Ingemann-Hansen T, et al: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225, 1989.
2. De Boer H, Blok G, van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86, 1995.
3. De Boer H, Blok GJ, Van Lingen A, et al: The consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 9:1319-1326, 1994.
4. Attanasio AF, Lamberts SWJ, Matranga AMC, et al: Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82-88, 1994.
5. Johannsson G, Mårin P, Lönn L, et al: Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 82:727-734, 1997.
6. Papadakis M, Grady D, Black D, et al: Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med 124:708-716, 1996.
7. J̈rgensen JOL, Muller J, Moller J, et al: Adult growth hormone deficiency. Horm Res 42:235-241, 1994.
8. Jørgensen JOL, Vahl N, Hansen TB, et al: Growth hormone versus placebo treatment for one year in growth hormone deficient adults: Increase in exercise capacity and normalization of body composition. Clin Endocrinol 45:681-688, 1996.
9. McGauley GA: Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 356:70-72, 1989.
10. Burman P, Broman JE, Hetta J, et al: Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with re-combinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 80:3585-3590, 1995.
11. Hunt SM, McEwen J, McKenna SP: Measuring health status: A new tool for clinicians and epidemiologists. J R Coll Gen Pract 35:185-188, 1985.
12. Johansson J, Larson G, Andersson M, et al: Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 61:57-66, 1995.
13. Holmes SJ, Shalet SM: Which adults develop side-effects of growth hormone replacement? Clin Endocrinol 43:143-149, 1995.
14. Hoffman DM, O'Sullivan AJ, Baxter RC, et al: Diagnosis of growth hormone deficiency in adults. Lancet 343:1064-1068, 1994.
15. Eddy RL, et al: Human growth hormone release: Comparison of various tests. Am J Med 56:179, 1974.
16. Boyd AE, Lebovitz HE, Pfeiffer MD: Stimulation of human-growth-hormone secretion by L-DOPA. N Engl J Med 283:1425-1429, 1970.
17. Mitchell ML, Byrne MJ, Sanchez Y, et al. Detection of growth hormone deficiency. The glucagon stimulation test. N Engl J Med 282:539-541, 1970.
18. Ghigo E, Goffi S, Nicolosi M, et al: Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J Clin Endocrinol Metab 71:1481-1485, 1990.
19. Procopio M, Maccario M, Savio P, et al: GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: Obesity and Cushing's syndrome in comparison with hypopituitarism. Panminerva Med 40(1):13-17, 1998.
20. Ghigo E, Bellone J, Aimaretti G, et al: Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 81:3323-3327, 1996.
21. Vestergaard P, Hoeck HC, Jakobsen PE, et al: Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Eur J Endocrinol 29(3):106-110, 1997.
22. Gil-Ad I, Gurewitz R, Marcovici O, et al: Effect of aging on human plasma growth hormone response to clonidine. Mech Ageing Dev 27:97-100, 1984.
23. Valetto MR, Bellone J, Baffoni C, et al: Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. Eur J Endocrinol 135:568-572, 1996.
24. Ho KY, Evans WS, Blizzard RM, et al. Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58, 1987.
25. DeBoer H, van der Veen, EA: Why retest young adults with childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 82:2032-2036, 1997.
26. Asa SL, Bilbao JM, Kovacs K, et al: Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: A distinct clinicopathologic entity. Ann Intern Med 95:166-171, 1981.
27. Rosén T, Bengtsson B: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336(8710): 285-288, 1990.
28. Bulow B, Hagmar L, Mikoczy A, et al: Increased cerebrovascular mortality in patients with hypopituitarism [see comments]. Clin Endocrinol 48(4):525-526, 1998.
29. Dunne FP, Elliot P, Gammage MD, et al: Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism. Clin Endocrinol 43(5):623-629, 1995.
30. Bates AS, Van't Hoff W, Jones PJ, et al: The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 81(3):1169-1172, 1996.
31. Markussis V, Beshyah SA, Fisher C, et al: Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340:1188-1192, 1992.
32. Pfeifer M, Verhovec R, Zizek B, et al: Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84(2):453-457, 1998.
33. Friend KE, Hartman ML, Pezzoli SS, et al: Both oral and transdermal estrogen increase growth hormone release in postmenopausal women - A clinical research center study. J Clin Endocrinol Metab 81:2250, 1996.
34. Cook DM, Ludlum WH, Cook MB: Route of estrogen helps to determine growth hormone replacement dose in growth hormone deficient adults, submitted for publication.
35. DeBoer H, Blok G-J, Voerman B, et al: The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. J Clin Endocrinol Metab 80:2069-2076, 1995.
36. DeBoer H, Blok G-J, Popp-Snijders C, et al: Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 81:1371-1377, 1996.
37. Moller J, Jørgensen JOL, Lauersen T, et al: Growth hormone dose regimens in adult GH deficiency: Effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) 39:403-408, 1993.
38. Knox J, Demling R, Wilmore D, et al: Increased survival after major thermal injury: The effect of growth hormone therapy in adults. J Trauma 39:526-530, 1995.
39. Fazio S, Sabatini D, Capaldo B, et al: A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334:809-814, 1996.
40. Knox JB, Wilmore DW, Demling RH, et al: Use of growth hormone for postoperative respiratory failure. Am J Surg 171:576-580, 1996.
41. Weaver JU, Thaventhiran L, Noonan K, et al: The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clin Endocrinol 41:639-648, 1994.
42. Ogilvy-Stuart AL, Ryder WDJ, Gattamaneni HR, et al: Growth hormone and tumor recurrence. BMJ 304:1601-1605, 1992.
43. Moshang T, Rundle AC, Graves DA, et al: Brain tumor recurrence in children treated with growth hormone: The National Cooperative Growth Study experience. J Pediatr 128(5):S4-7, 1996.